Worldwide Allergy Immunotherapy Market Forecast to Draw a Promising Growth of 10.85% by 2023
Market Highlights: The global allergy immunotherapy market has been evaluated as a rapidly growing market and it is expected to continue growing in the near future. Allergy immunotherapy is a disease-adapting therapy, effective for the treatment allergic rhinitis/conjunctivitis, allergic asthma, peanuts allergy, cat allergy, and stinging insect hypersensitivity. According to the World Allergy Organization (WAO), approximately 10%-40% of the global population is suffering from allergy in 2013. Increasing demand for advance allergy treatment, increasing research and development activity, increasing research in improving the allergy treatment and introduction of new immunotherapeutic drugs are the major driving forces for the global allergy immunotherapy market. The demand for allergy immunotherapy treatment in emerging markets of Asia and Latin America is continuously growing that is another major factor for the market growth. Increasing knowledge of the immunotherapy, new product launches, increasing funding for R&D, and approvals are leading the market growth. Ask for Sample Copy: https://www.marketresearchfuture.com/sample_request/1517 .
Regional Analysis: Considering the global scenario of the allergy immunotherapy market, there are four main regions, the Americas, Europe, Asia Pacific, and Middle East & Africa. Europe is holding the largest market share in global allergy immunotherapy market. Some major factors that attribute the growth of Europe allergy immunotherapy market are, rise in prevalence of chronic diseases like allergy, asthma, diabetes and hypertension. Europe consists of two regions namely Western Europe and Eastern Europe. Western Europe is generating more revenue as compared to Eastern Europe. The Americas are the second largest market share. The Americas mainly include North America and Latin America. Some key factors that are driving the growth for the American Allergy Immunotherapy market growth are increasing prevalence of allergic asthma, food allergy, and eczema, advanced healthcare facilities, and funding for research and new product or therapy development. Asia Pacific is the fastest growing market. Increasing adoption, improving healthcare infrastructure and rising awareness about allergy immunotherapy are driving the growth for this market. Improving healthcare infrastructure and demand of allergy immunotherapy treatment are the major drivers for the Middle East & Africa allergy immunotherapy market.
Segmentation: Global allergy immunotherapy market has been segmented on the basis of allergy type which comprise allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies. On the basis of treatment, it is segmented into facial line correction treatment, Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT). Sublingual